"Cocoa May Help Keep Brain Healthy"

Two Mount Sinai Research Papers Present Evidence of Distinct Molecular Differences Between Brain Tissue from Living People and Tissue Collected After Death

Mount Sinai Is First in the Nation to Perform Deep Brain Stimulation Implant as Part of Clinical Trial for Depression

Dysregulation of the Brain’s Reward Learning System Is Identified by Scientists as a Potential Driver and Treatment Target for Cocaine Addiction

Decoding Depression: Researchers Identify Crucial Biomarker That Tracks Recovery From Treatment-Resistant Depression

Cocaine Use Disorder Alters Gene Networks of Neuroinflammation and Neurotransmission in Humans

Mount Sinai Receives $2 Million From the Parkinson’s Foundation to Investigate Underlying Cell-Specific Mechanisms of the Condition

Mount Sinai Launches Large-Scale Genetic Sequencing Project with the Regeneron Genetics Center

A Stem Cell Model From Mount Sinai Could Help Unravel the Complex Biology Behind Some Psychiatric Disorders

Mount Sinai Leads Multi-Site Study Evaluating a Novel Intervention Designed to Improve Community Re-Entry Outcomes for Justice-Involved Individuals With Brain Injuries

Blocking a Hormone That Acts on Brain Cells Limits Alzheimer’s Symptoms in Mice, Mount Sinai Researchers Discover

Allen Institute Appoints Mount Sinai Neuroscientist as a Next Generation Leader